| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 47,431 | 48,442 | 40,673 | 50,725 | | Cost of Revenue | 20,129 | 22,526 | 19,687 | 20,479 | | | Gross Profit | 27,302 | 25,916 | 20,986 | 30,246 | | | Operating Expenses | | Research Development | 10,196 | 9,371 | 7,996 | 13,122 | | Selling General and Administrative | 11,344 | 12,519 | 4,678 | 18,179 | | Non Recurring | 273 | 999 | (14,653) | 14,808 | | Others | 434 | 459 | (193) | 773 | | | | Total Operating Expenses | 22,247 | 23,348 | (2,172) | 46,882 | | | | Operating Income or Loss | 5,055 | 2,568 | 23,158 | (16,636) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 333 | 782 | 383 | 508 | | Earnings Before Interest And Taxes | 5,388 | 3,350 | 23,541 | (16,128) | | Interest Expense | 57 | 271 | 490 | 952 | | Income Before Tax | 5,331 | 3,079 | 23,051 | (17,080) | | Income Tax Expense | 906 | 8 | 101 |
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,425 | 3,071 | 22,950 | (17,080) | | | Non-recurring Events | | Discontinued Operations | (67) | 5,885 | (14,800) | 16 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,358 | 8,956 | 8,150 | (17,064) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,358 | $8,956 | $8,150 | ($17,064) |
|
0.31% Nasdaq 
0.05%
Income Statement
